CLINICAL_TRIALS
trial_result
· 2014-02-10
Clinical Trial Update: Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder [Phase 3]
Summary
A Phase 3 long-term study evaluated aripiprazole as an adjunctive treatment for adults with major depressive disorder. The results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-02-10